Table 1 Patient and tumor characteristics of the study cohort stratified by recurrence
Patient Groups | P-Value | |||||||
|---|---|---|---|---|---|---|---|---|
No Recurrence | Recurrence | |||||||
Count | Row N % | Median (IQR) | Count | Row N % | Median (IQR) | |||
Age | 49 | 43.4% | 70 (62, 78) | 64 | 56.6% | 75 (65, 83) | 0.290 | |
Sex | Female | 6 | 35.3% | 11 | 64.7% | 0.466 | ||
Male | 43 | 44.8% | 53 | 55.2% | ||||
Grade | 1 | 35 | 45.5% | 42 | 54.5% | 0.765 | ||
2 | 1 | 50.0% | 1 | 50.0% | ||||
3 | 13 | 38.2% | 21 | 61.8% | ||||
Stage | Ta | 38 | 46.3% | 44 | 53.7% | 0.299 | ||
T1 | 11 | 35.5% | 20 | 64.5% | ||||
CIS | No | 47 | 42.7% | 63 | 57.3% | 0.409 | ||
Yes | 2 | 66.7% | 1 | 33.3% | ||||
Number Of Tumors | Single Tumor | 14 | 40.0% | 21 | 60.0% | 0.885 | ||
2–7 Tumors | 29 | 44.6% | 36 | 55.4% | ||||
8 or More | 6 | 46.2% | 7 | 53.8% | ||||
Tumor Diameter | < 30 mm | 36 | 47.4% | 40 | 52.6% | 0.218 | ||
30 mm or more | 13 | 35.1% | 24 | 64.9% | ||||
Past TCC | No | 33 | 41.3% | 47 | 58.8% | 0.480 | ||
Yes | 16 | 48.5% | 17 | 51.5% | ||||
WBC | 49 | 43.4% | 7.9 (7.05, 9.66) | 64 | 56.6% | 7.71 (6.17, 10) | 0.373 | |
NLR | 49 | 43.4% | 2.35 (1.7, 3.43) | 64 | 56.6% | 2.87 (2.29, 4.65) | 0.287 | |
NLR-2.5 | Below 2.5 | 28 | 59.6% | 19 | 40.4% | 0.004 | ||
Above 2.5 | 21 | 31.8% | 45 | 68.2% | ||||
Treatment Type | No Treatment | 15 | 34.1% | 29 | 65.9% | 0.053 | ||
MMC | 12 | 37.5% | 20 | 62.5% | ||||
BCG | 22 | 59.5% | 15 | 40.5% | ||||